Sex Differences in Subclinical Cardiovascular Organ Damage After Renal Transplantation: A Single-Center Cohort Study

Tabea Stocklassa1, Bianca Borchert-Mörlins1, Nima Memaran1

  • 1Department of Pediatric Kidney, Liver and Metabolic Diseases, Visceral and Transplantation Surgery, Hannover Medical School, Hannover, Germany.

Insights

Cardiovascular disease risk differs by sex after kidney transplants. Women experienced increased heart muscle mass, but calcium channel blockers (CCBs) improved outcomes, particularly for female recipients.

Area of Science:

  • Nephrology
  • Cardiology
  • Transplantation Medicine

Background:

  • Cardiovascular disease (CVD) is a primary cause of mortality post-renal transplantation (RT).
  • Sex-specific variations in CVD are established in the general population.
  • Subclinical cardiovascular (CV) organ damage requires investigation in RT recipients.

Purpose of the Study:

  • To investigate sex-specific differences in the prevalence and progression of subclinical CV organ damage.
  • To evaluate these differences within the first year following renal transplantation.

Main Methods:

  • Prospective longitudinal study of 121 renal transplant recipients (64% male, mean age 51 years).
  • Assessment of CV risk factors, left ventricular mass index (LVMI), and pulse wave velocity (PWV) at RT and 1 year post-RT.
  • Multivariable analysis to identify independent predictors of LVMI changes.

Main Results:

  • Women presented with less pre-existing CVD and better blood pressure (BP) control, with lower use of calcium channel blockers (CCBs).
  • Despite comparable graft function, LVMI increased in women and decreased in men (p=0.027).
  • Female sex and systolic BP were independently associated with LVMI changes.
  • Women on CCBs demonstrated reduced LVMI and PWV.

Conclusions:

  • Renal transplantation is associated with sex-specific changes in left ventricular mass.
  • Calcium channel blockers may mitigate CV risk post-RT, especially in female recipients.
  • Further research into sex-based effects and CCB utilization in RT patients is warranted.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
177
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
159
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
588
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
488
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
378